Metabolix, Inc. Share Price Nasdaq
Equities
US5910188094
Biotechnology & Medical Research
Sales 2024 * | 2.25M 179M | Sales 2025 * | 4M 319M | Capitalization | 3.31M 264M |
---|---|---|---|---|---|
Net income 2024 * | -11M -877M | Net income 2025 * | -13M -1.04B | EV / Sales 2024 * | 1.47 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.83 x |
P/E ratio 2024 * |
-0.28
x | P/E ratio 2025 * |
-0.25
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 0% |
Latest transcript on Metabolix, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Oliver Peoples
FOU | Founder | 66 | 31/05/92 |
Charles Haaser
DFI | Director of Finance/CFO | 68 | 31/12/07 |
Kristi Snell
CTO | Chief Tech/Sci/R&D Officer | 56 | 31/12/96 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 67 | 30/09/06 | |
Richard Hamilton
BRD | Director/Board Member | 61 | 01/03/17 |
Oliver Peoples
FOU | Founder | 66 | 31/05/92 |
1st Jan change | Capi. | |
---|---|---|
+22.81% | 46.81B | |
+46.56% | 41.29B | |
-1.88% | 41.37B | |
-6.20% | 28.87B | |
+11.33% | 26.06B | |
-21.00% | 19.13B | |
-1.43% | 11.96B | |
+30.73% | 12.39B | |
-0.48% | 12.08B |